Tiankang Bio: Tiankang Bio (002100) announced on the evening of December 12 that Tiankang Bio (stock code: 874339), a holding subsidiary of the company, intends to apply for public offering of shares to unspecified qualified investors and listing on the Beijing Stock Exchange. As of the disclosure date of the announcement, Tiankang Bio's public offering of shares to unspecified qualified investors and listing on the North Stock Exchange are under counseling.At least 15 people were killed and 64 injured in the attack on the capital of Northern Darfur, Sudan. According to the Sudan Tribune, the Sudan Rapid Support Force shelled a livestock market and Zam Zam refugee camp in the south of El Fasher on the 11th local time, killing at least 15 people and injuring 64 others, including 10 women and 5 children. (Zhongxin. com)Laimei Pharmaceutical Co., Ltd.: The controlling shareholder intends to transfer 23.43% of the shares by agreement. Laimei Pharmaceutical announced that Zhongheng Group, the controlling shareholder, intends to transfer 247 million shares of the company's unrestricted tradable A shares by public solicitation of the transferee, accounting for 23.43% of the company's total share capital, and the transfer price is not less than 4.42 yuan/share. If the share transfer is completed, the controlling shareholder and actual controller of the company may change.
Market News: A fire broke out at Kaliningrad Shipyard in Russia.CITIC Securities: The resonance between supply and demand of medical beauty accelerates the space expansion, and the difference in operating ability promotes the evolution of the industry structure. CITIC Securities Research Report stated that the medical beauty industry has both medical and consumption attributes, and the medical attribute has strong product-driven characteristics, while the consumption attribute has high operating ability requirements. The medical beauty botulinum toxin track is also affected by the dual attributes of medicine and consumption: 1) The increase in penetration rate, the acceleration of compliance substitution and the extension of indications have brought about high demand for medical beauty botulinum toxin, and with the recent supply expansion, the industry scale has experienced high growth; 2) The iteration of product innovation is slow, brand barriers are created through marketing, doctors are empowered through direct sales, and control is strengthened to enhance product competitiveness. Recently, a variety of medical botulinum toxins in China have been approved, and the promotion of low-priced products is expected to push up the penetration rate, and enterprises with strong operational capabilities will enter the market or promote the evolution of the pattern.Daiwa raised Tesla's target price to $420.
South Korea's Seoul Composite Index rose to 1%.Truck manufacturer Paccar recalled more than 220,000 American cars due to electronic system problems. The National Highway Traffic Safety Administration (NHTSA) said on Thursday that truck manufacturer Paccar recalled 220,972 cars in the United States because there was a problem with the electronic control unit (ECU), which might affect the systems related to braking and stability control. NHTSA said that the recalled vehicles included some Peterbilt and Kenworth cars produced in 2021-2025.Add 121.3 billion cubic meters! The proven reserves of Fuling shale gas field have exceeded one trillion cubic meters. The reporter learned from China Petrochemical today (12th) that China has made great progress in shale gas exploration. The proven reserves in Nanchuan block of Fuling shale gas field have increased by 121.356 billion cubic meters, and the accumulated proven reserves have reached one trillion cubic meters, which has added protection to national energy security. (CCTV News)
Strategy guide
12-13
Strategy guide
Strategy guide
12-13
Strategy guide 12-13
Strategy guide
12-13
Strategy guide 12-13